Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HOXA distal transcript antisense RNA | 0.575 | 0.654 |
|
phenotype | 0.100 | None | 1.000 | 7 | 6 | 2016 | 2019 | |||||||||
|
TCF21 antisense RNA inducing promoter demethylation | 0.821 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2017 | 2019 | |||||||||
|
SPRY4 antisense RNA 1 | 0.890 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2018 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2227 |
|
phenotype | 0.100 | None | 1.000 | 4 | 5 | 2017 | 2019 | |||||||||||
|
long intergenic non-protein coding RNA 1478 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2016 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2398 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2016 | 2018 | |||||||||
|
BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2015 | 2018 | |||||||||
|
DDN and PRKAG1 antisense RNA 1 | 0.890 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2016 | 2019 | |||||||||
|
DBH antisense RNA 1 | 0.780 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2016 | 2019 | |||||||||
|
cancer susceptibility 15 | 0.603 | 0.577 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2017 | 2019 | |||||||||
|
ZBTB44 divergent transcript |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2017 | 2019 | |||||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | |||||||||
|
zinc finger protein 969, pseudogene |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||||
|
long intergenic non-protein coding RNA 1358 | 0.931 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1150 | 0.931 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 824 | 0.695 | 0.346 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||
|
PKN2 antisense RNA 1 | 0.769 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2356 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||
|
H19 imprinted maternally expressed transcript | 0.494 | 0.923 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2018 | |||||||||
|
HOXA cluster antisense RNA 2 | 0.663 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2017 | |||||||||
|
testis expressed 41 | 0.743 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1184 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||
|
PLCE1 antisense RNA 1 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
MIR29B2 and MIR29C host gene | 0.839 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
MAPT antisense RNA 1 | 0.711 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 |